ENTRY       D04747                      Drug
NAME        Lisdexamfetamine dimesylate (USAN);
            Lisdexamfetamine mesilate (JAN);
            Vyvanse (TN);
            Elvanse (TN)
PRODUCT     VYVANSE (Takeda Pharmaceuticals America)
  GENERIC   LISDEXAMFETAMINE DIMESYLATE (Alvogen)
            LISDEXAMFETAMINE DIMESYLATE (Amneal Pharmaceuticals LLC)
            LISDEXAMFETAMINE DIMESYLATE (Ascent Pharmaceuticals)
            LISDEXAMFETAMINE DIMESYLATE (Ascent Pharmaceuticals)
            LISDEXAMFETAMINE DIMESYLATE (Hikma Pharmaceuticals USA)
            LISDEXAMFETAMINE DIMESYLATE (Lannett Company)
            LISDEXAMFETAMINE DIMESYLATE (Mylan Pharmaceuticals)
            LISDEXAMFETAMINE DIMESYLATE (Solco Healthcare US)
            LISDEXAMFETAMINE DIMESYLATE (SpecGx LLC)
            LISDEXAMFETAMINE DIMESYLATE (Sun Pharmaceutical Industries)
FORMULA     C15H25N3O. (CH4SO3)2
EXACT_MASS  455.176
MOL_WEIGHT  455.5898
REMARK      Therapeutic category: 1179
            ATC code: N06BA12
            Chemical structure group: DG00973
            Product (DG00973): D04747<JP/US>
EFFICACY    Stimulant (central)
  DISEASE   Attention deficit hyperactivity disorder [DS:H01895]
            Binge eating disorder [DS:H01703]
COMMENT     Treatment of attention deficit hyperactivity disorder (ADHD)
            Active form of prodrug: Dextroamphetamine [DR:D03740]
TARGET      SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
            SLC6A3 (DAT1) [HSA:6531] [KO:K05036]
  PATHWAY   hsa04721(6530+6531)  Synaptic vesicle cycle
            hsa04728(6531)  Dopaminergic synapse
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
                N06BA Centrally acting sympathomimetics
                 N06BA12 Lisdexamfetamine
                  D04747  Lisdexamfetamine dimesylate (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Attention Deficit Hyperactivity Disorder Agents, Amphetamines
               Lisdexamfetamine
                D04747  Lisdexamfetamine dimesylate (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1179  Others
                 D04747  Lisdexamfetamine dimesylate (USAN); Lisdexamfetamine mesilate (JAN)
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D04747  Lisdexamfetamine dimesylate (USAN) &lt;JP/US&gt;
                SLC6A3 (DAT1)
                 D04747  Lisdexamfetamine dimesylate (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04747
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04747
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04747
            Prodrugs [br08324.html(DG00973)]
             DG00973
DBLINKS     CAS: 608137-33-3
            PubChem: 47206566
            LigandBox: D04747
ATOM        29
            1   C8x C     1.7500   -5.6700
            2   C8x C     1.7500   -7.0700
            3   C8x C     2.9624   -7.7700
            4   C8x C     4.1749   -7.0700
            5   C8y C     4.1749   -5.6700
            6   C8x C     2.9624   -4.9700
            7   C1b C     5.4060   -4.9590
            8   C1c C     6.6112   -5.6547
            9   N1b N     7.7935   -4.9719
            10  C1a C     6.6116   -7.0696
            11  C5a C     8.9875   -5.6612
            12  C1c C    10.1754   -4.9752
            13  O5a O     8.9877   -7.0697
            14  C1b C    11.3665   -5.6629
            15  C1b C    12.5559   -4.9761
            16  C1b C    13.7462   -5.6634
            17  C1b C    14.9361   -4.9763
            18  N1a N    16.1262   -5.6635
            19  N1a N    10.1755   -3.5702
            20  S4a S    22.2859   -5.9458
            21  C1a C    20.8827   -5.9458
            22  O1d O    23.6891   -5.9458
            23  O1d O    22.2859   -4.5426
            24  O1d O    22.2859   -7.3491
            25  S4a S    22.2859   -5.9458
            26  C1a C    20.8827   -5.9458
            27  O1d O    23.6891   -5.9458
            28  O1d O    22.2859   -4.5426
            29  O1d O    22.2859   -7.3491
BOND        27
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    8  10 1 #Up
            11    9  11 1
            12   11  12 1
            13   11  13 2
            14   12  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   17  18 1
            19   12  19 1 #Up
            20   20  21 1
            21   20  22 1
            22   20  23 2
            23   20  24 2
            24   25  26 1
            25   25  27 1
            26   25  28 2
            27   25  29 2
BRACKET     1    18.9700   -7.9100   18.9700   -3.5700
            1    25.2000   -3.5700   25.2000   -7.9100
            1  2
  ORIGINAL  1   20  21  22  23  24
  REPEAT    1   25  26  27  28  29
///
